Member Info for mazik

Rocket set off

Contact tracing and Covid seems to be implemented in UK and USA mentioned this afternoon news and On CNN last night

Womo agree with u, very positive in front of us

I assume US rollout of the educational software should be done soon....

FDBK Will be better placed to support front line workers in NHS

Contact tracing will be necessity

Seems that the immunity.passport will be reality all over the world making CTEA ahead with its technology..imo

Topped up another 250k and that's my lot shy of 500k. .feel its a good holding for this year...

Heck of a shake , same play as yesterday...Lucky who are buying before midday.

Please could someone let me know Brian Thompson owning over 29% of CTEA, wonder if he is part of the managment? or he has invested to takeover?

same trend as yesterday, weak until 10 am...then 50% up midday...enjoy the mm play

MM wants the weak holders to give up their holding for the next journey :-) hence the shake

Dnd see the potential here. The feedback from the pilot has been used to hone the tool and enable an improved version of Bleepa® to have been developed which is now being deployed to assist the Trust in delivering its COVID-19 response, feel now we need the CE approval and further rollout within NHS we will be rerated to multiples of where we stand double figures will be in sight IMO

Dnd agree with u , NHS PPE in crisis, the Bleepa delivery system will be the backbone of NHS frontline now and for the future. 10p isa fair price on CE approval..IMO

Its all blue , good signal to buy.

MM are doing their best to take shares from the weak, this is going one way...north towards 3p plus and double figures on CE approval, intresting times IMO

CE approval and this will be rerated towards double figures...imo

Adamk this will rerate past the initial target of 3p and that was last year when it was over 2p before the Bleepa rollout scheduled date was planned.

The market earlier on did not realise the potential , its rerating now and will follow suit this week...The frontline of NHS needs the Bleepa rollout and has come out when needed most..IMO

The short termers are out, now the investors who seems to value the rollout of Bleepa are buying...imo